Secukinumab (anti-IL-17A)

Synonyms: Cosentyx, AIN457

Catalog No.A2025 Purity: 99.82%

Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.

Click to purchase the isotype control of Secukinumab (anti-IL-17A)

Selleck's Secukinumab (anti-IL-17A) has been cited by 2 publications

Purity & Quality Control

Batch: A202501 Purity: 99.82% Protein concentration: 5.00mg/ml Endotoxin Level: <1EU/mg

99.82

Choose Selective Interleukins Inhibitors

Biological Activity

Description	Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.

In Vitro
In vitro	Secukinumab can reduce cell growth in the miR130b-knockdown OCI-ly10 co-culture system.^[1]
Cell Research:	MTT assay was adopted to measure cell growth in the control inhibitor or miR130b inhibitor transfected OCI-ly10 co-culture system upon treatment with or without IL17 inhibitor.

In Vitro

In vitro

Secukinumab can reduce cell growth in the miR130b-knockdown OCI-ly10 co-culture system.^[1]

Cell Research:

MTT assay was adopted to measure cell growth in the control inhibitor or miR130b inhibitor transfected OCI-ly10 co-culture system upon treatment with or without IL17 inhibitor.

In Vivo
In vivo	Secukinumab administration significantly attenuates AAV8-IRF8 mediated recruitment of neutrophils, also downregulates the autophagy level and inhibits the release of either autophagy-dependent or independent chemokines in vivo.^[2]
Animal Research	Animal Models: C57BL/6 mice, IRF8 FLOX mice (C57BL/6J background) Dosages: 200 μg Administration: i.p. Reference: https://pubmed.ncbi.nlm.nih.gov/34400126/

References
[1] Sun R, et al. Signal Transduct Target Ther. 2022 Mar 18;7(1):80. [2] Shi G, et al. Biochem Pharmacol. 2021 Oct;192:114728.

References

Product Details

CAS No.	1229022-83-6
Isotype	Human IgG1
Source	Human
Formulation	PBS buffer, pH 7.2
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field